Primary Site >> Pancreatic Cancer

Gene >> DPP4

Journal: Int J Pancreatol. 1989 May;4(4):391-406.
Title: Modulation of enzymatic activities during spontaneous and induced differentiation in a human pancreatic adenocarcinoma cell line CAPAN-1.
Author: Bensaadi, N|Clemente, F|Vaysse, N
PMID: 2543714
Journal: Oncol Res. 2009;17(8):339-45.
Title: Bone marrow-derived progenitor cells could modulate pancreatic cancer tumorigenesis via peritumoral microenvironment in a rat model.
Author: Pan, Jen-Jung|Oh, Seh-Hoon|Lee, Wayne C|Petersen, Bryon E
PMID: 19544970
Journal: Endocr Relat Cancer. 2012 Sep 5;19(5):F77-88.
Title: GLP1 and cancer: friend or foe?
Author: Vangoitsenhoven, Roman|Mathieu, Chantal|Van der Schueren, Bart
PMID: 22691625
Journal: Endocr Pract. 2013 Nov-Dec;19(6):1050-61.
Title: The placement of DPP-4 inhibitors in clinical practice recommendations for the treatment of type 2 diabetes.
Author: Davidson, Jaime A
PMID: 24126227
Journal: J Endocrinol. 2014 Mar 7;221(1):T43-61.
Title: Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology?
Author: Lamont, Benjamin J|Andrikopoulos, Sofianos
PMID: 24424288
Journal: Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):787-812.
Title: The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].
Author: Filippatos, Theodosios D|Athyros, Vasilios G|Elisaf, Moses S
PMID: 24746233
Journal: J Clin Diagn Res. 2015 Dec;9(12):FC14-6.
Title: Evaluation of Anti Cancer Effects of DPP-4 Inhibitors in Colon Cancer- An Invitro Study.
Author: Amritha, C A|Kumaravelu, Punnagai|Chellathai, D Darling
PMID: 26816911
Journal: Expert Opin Drug Saf. 2016;15(2):249-64.
Title: Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation.
Author: Yabe, Daisuke|Seino, Yutaka
PMID: 26607297
Journal: Pancreatology. 2016 Jan-Feb;16(1):2-7.
Title: GLP-1 mimetic drugs and the risk of exocrine pancreatic disease: Cell and animal studies.
Author: Williams, John A
PMID: 26751948
Journal: Pancreatology. 2016 Sep-Oct;16(5):829-38.
Title: Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
Author: Busek, Petr|Vanickova, Zdislava|Hrabal, Petr|Brabec, Marek|Fric, Premysl|Zavoral, Miroslav|Skrha, Jan|Kmochova, Klara|Laclav, Martin|Bunganic, Bohus|Augustyns, Koen|Van Der Veken, Pieter|Sedo, Aleksi
PMID: 27320722
Journal: Tumour Biol. 2016 Oct 7. pii: 10.1007/s13277-016-5315-4.
Title: Suppression of CD26 inhibits growth and metastasis of pancreatic cancer.
Author: Ye, Chunxiang|Tian, Xiuyun|Yue, Guanjun|Yan, Liang|Guan, Xiaoya|Wang, Shan|Hao, Chunyi
PMID: 27718126
Journal: Biomed Pharmacother. 2018 Jan;97:1250-1258.
Title: Vildagliptin loaded triangular DNA nanospheres coated with eudragit for oral delivery and better glycemic control in type 2 diabetes mellitus.
Author: Baig, Mirza Muhammad Faran Ashraf|Khan, Sara|Naeem, Muhammad Ahsan|Khan, Ghulam Jilany|Ansari, Muhammad Tayyab
PMID: 29145151
Journal: Front Endocrinol (Lausanne). 2018 Mar 5;9:62.
Title: Clinical and Physiological Characterization of Elevated Plasma Glucagon-Like Peptide-1 Levels (Hyperglipemia) in a Dipeptidyl Peptidase IV Mutation Carrier.
Author: Zhao, Dandan|Zhao, Shaoqian|Wang, Xiao|Su, Mingbo|Liu, Wen|Ma, Qinyun|Hong, Jie|Gu, Weiqiong|Li, Jingya|Liu, Ruixin|Ning, Guang|Wang, Jiqiu|Zhang, Yifei
PMID: 29556215